Insights into the multistep transformation process of lymphomas: Igh-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas

Leukemia

Volumn 19, Issue 8, 2005, Pages 1452-1458

  Schmitz, Roland ^a   Renne C ^b   Rosenquist, R ^c   Tinguely, M ^d   Distler, V ^a,b   Menestrina, F ^e   Lestani, M ^e   Stankovic, T ^f   Austen, B ^f   Brauninger A ^b   Hansmann, M L ^b   Kuppers R ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

BCL2; CCND1; Composite lymphoma; Hodkin's lymphoma; TP53

Indexed keywords

ATM PROTEIN; FAS ANTIGEN; I KAPPA B ALPHA; PROTEIN P53;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; FOLLICULAR LYMPHOMA; GENE MUTATION; GENETIC ANALYSIS; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 23744505553     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403841     Document Type: Article

References (47)

1. Rosenquist R, Menestrina F, Lestani M, Küppers R, Hansmann ML, Bräuninger A. Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma. Lab Invest 2004; 84: 253-262.
2. Rosenquist R, Roos G, Erlanson M, Küppers R, Bräuninger A, Hansmann ML. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses. Eur J Haematol 2004; 73: 210-214.
3. Tinguely M, Rosenquist R, Sundstrom C, Amini RM, Küppers R, Hansmann ML et al. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center. Am J Surg Pathol 2003; 27: 1483-1488.
4. van den Berg A, Maggio E, Rust R, Kooistra K, Diepstra A, Poppema S. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood 2002; 100: 1425-1429.
5. Küppers R, Sousa AB, Baur AS, Strickler JG, Rajewsky K, Hansmann ML. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL. Mol Med 2001; 7: 285-292.
6. Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Huhn D, Stein H. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 1999; 17: 3804-3809.
7. Bräuninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 1999; 340: 1239-1247.
8. Küppers R, Zhao M, Hansmann ML, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12: 4955-4967.
9. Küppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003; 3: 801-812.
10. Jungnickel B, Staratschek-Jox A, Bräuninger A, Spieker T, Wolf J, Diehl V et al. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191: 395-402.
11. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 1999; 18: 3063-3070.
12. Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F et al. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999; 94: 3129-3134.
13. Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 2003; 101: 3681-3686.
14. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961-2969.
15. Montesinos-Rongen M, Roers A, Küppers R, Rajewsky K, Hansmann ML. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 1999; 94: 1755-1760.
16. Maggio EM, van den Berg A, de Jong D, Diepstra A, Poppema S. Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma. Am J Pathol 2003; 162: 29-35.
17. Maggio EM, Stekelenburg E, van den Berg A, Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 2001; 94: 60-66.
18. Müschen M, Re D, Bräuninger A, Wolf J, Hansmann ML, Diehl V et al. Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells. Cancer Res 2000; 60: 5640-5643.
19. Gravel S, Delsol G, Al Saati T. Single-cell analysis of the t(14;18)(q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells. Blood 1998; 91: 2866-2874.
20. Miura I, Tamura A, Taniwaki M, Nakamura S, Nakamine H, Yoshino T et al. Detection of t(14; 18)(q32;q21) in hyperdiploid cells by fluorescence in situ hybridization in a patient with Hodgkin disease. Cancer Genet Cytogenet 2000; 123: 97-101.
21. Liberzon E, Avigad S, Yaniv I, Stark B, Avrahami G, Goshen Y et al. Molecular variants of the ATM gene in Hodgkin's disease in children. Br J Cancer 2004; 90: 522-525.
22. Takagi M, Tsuchida R, Oguchi K, Shigeta T, Nakada S, Shimizu K et al. Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease. Blood 2004; 103: 283-290.
23. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808-822.
24. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413-5417.
25. Volpe G, Vitolo U, Carbone A, Pastore C, Bertini M, Botto B et al. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes Cancer 1996; 16: 21-30.
26. Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998; 92: 3018-3024.
27. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pedersen A, Anderson JR et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302-4310.
28. Gumy-Pause F, Wacker P, Sappino AP. ATM gene and lymphoid malignancies. Leukemia 2004; 18: 238-242.
29. Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM. ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 2002; 43: 1563-1571.
30. Noppe SM, Heirman C, Bakkus MH, Brissinck J, Schots R, Thielemans K. The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism. Br J Haematol 1999; 107: 625-640.
31. Liu J, Johnson RM, Traweek ST. Rearrangement of the BCL-2 gene in follicular lymphoma. Detection by PCR in both fresh and fixed tissue samples. Diagn Mol Pathol 1993; 2: 241-247.
32. Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987; 80: 1512-1515.
33. Zoldan MC, Inghirami G, Masuda Y, Vandekerckhove F, Raphael B, Amorosi E et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol 1996; 93: 475-486.
34. Villuendas R, Pezzella F, Gatter K, Algara P, Sanchez-Beato M, Martinez P et al. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations. J Pathol 1997; 181: 51-61.
35. Nadel B, Marculescu R, Le T, Rudnicki M, Böcskör S, Jäger U. Novel insights into the mechanism of t(14;18)(q32;q21) translocation in follicular lymphoma. Leuk Lymphoma 2001; 42: 1181-1194.
36. Torlakovic E, Tierens A, Dang HD, Delabie J. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol 2001; 159: 1807-1814.
37. Re D, Münschen M, Ahmadi T, Wickenhauser C, Staratschek-Jox A, Holtick U et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res 2001; 61: 2080-2084.
38. Stein H, Marafioti T, Foss HD, Laumen H, Hummel M, Anagnostopoulos I et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97: 496-501.
39. Schwering I, Bräuninger A, Klein U, Jungnickel B, Tinguely M, Diehl V et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003; 101: 1505-1512.
40. Hell K, Lorenzen J, Fischer R, Hansmann ML. Hodgkin cells accumulate mRNA for bcl-2. Lab Invest 1995; 73: 492-496.
41. Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL et al. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 1991; 21: 1905-1910.
42. Garcia JF, Camacho FI, Morente M, Fraga M, Montalban C, Alvaro T et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003; 101: 681-689.
43. Tzankov A, Zimpfer A, Lugli A, Krugmann J, Went P, Schraml P et al. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. J Pathol 2003; 199: 201-207.
44. Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T et al. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 1999; 97: 767-777.
45. Müschen M, Rajewsky K, Krönke M, Küppers R. The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol 2002; 23: 75-80.
46. Koduru PR, Raju K, Vadmal V, Menezes G, Shah S, Susin M et al. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 1997; 90: 4078-4091.
47. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994; 265: 346-355.